TcLand Expression makes board appointment
This article was originally published in Scrip
Executive Summary
TcLand Expression (France), a company focused on development of gene expression biomarkers in transplantation and autoimmune disorders, has appointed Patrick Terry as a new member of its board of directors. He is the co-founder and former director of the personalised medicine company Genomic Health. Mr Terry is also a founder of the Personalized Medicine Coalition, Coalition for 21st Century Medicine and co-founder and former president of the International Genetic Alliance.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.